Skip to main content
    R

    Rallybio Corp (RLYB)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $15.43
    -0.30 (-1.88%)

    Market Cap: $88.03M

    Last updated: Nov 17, 2026 at 11:04 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    57%(12/21)
    Avg Surprise
    +26.98%
    Streak
    1 Q

    Upcoming Estimates

    Report date not yet scheduledPeriod ending Dec 31, 2026
    EPS Consensus-$1.61
    RangeN/A
    3 analysts
    Revenue Consensus
    N/A
    RangeN/A
    3 analysts

    Dividends

    Dividend Metrics

    Forward Yield0.00%
    Forward Annual Dividend$0.00
    Payout Ratio0.00%
    Pay MonthsNov

    Key Metrics

    Valuation
    P/E RatioN/AEV/EBITDA-0.10x
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit Margin6177.00%Operating Margin-5051.00%
    ROE34.50%ROICN/A
    Financial Health
    Debt/Equity0.00xInterest CoverageN/A
    Current Ratio28.87xQuick Ratio28.87x
    Trading Statistics
    Beta-0.77Avg Volume36.41K
    52-Week High$17.5752-Week Low$3.67

    Technical Indicators Dashboard

    As of Nov 16, 2026, the price is 51.2% above its 50-day moving average, and the 50-day average is above the 200-day average. The 14-day RSI is 80.9, above 70, the overbought line.

    Moving Averages

    SMA 10$14.99
    SMA 20$11.84
    SMA 50$10.20
    SMA 200$7.61
    EMA 10$14.51
    EMA 20$12.88
    EMA 50$10.93
    EMA 200$8.01

    MACD

    Line: 1.86Signal: 1.42Hist: 0.44

    ADX

    ADX: 34.8+DI: 0.9-DI: 2.3

    Aroon & PSAR

    Aroon UpN/A
    Aroon Down100.0
    PSAR$16.34

    Bollinger Bands

    Upper Band$19.03
    Lower Band$4.65
    %B Position12144%(Upper)
    Band Width0.75

    RSI (14-Day)

    Overbought
    80.9

    Momentum Oscillators

    Stoch %K29.3
    Stoch %D30.9
    Williams %R-75.2
    ROC (10d)81.3%
    Momentum6.92
    CCI (20d)61.3
    MFI (14d)56.5

    Volatility Measures

    ATR (14d)$4.53(29.4%)
    StdDev (20d)3.59
    Hist Vol306.4%(High)

    Volume Flow

    VWAP$15.50
    OBV168.9M
    AD Line6.2B
    CMF (20d)-25.410

    Volume Metrics

    Avg Vol (20d)37.8K
    Vol Ratio1.2x
    VWMA (20d)$11.69

    Pivot Points

    R3$16.13
    R2$15.96
    R1$15.84
    Pivot Point$15.67
    S1$15.55
    S2$15.38
    S3$15.26

    Advanced Oscillators

    TSI66.49
    Ultimate Osc37.6
    KST566.41

    Financial Performance

    Related GNG Research

    No research available

    Be the first to write about RLYB

    News

    RLYB Valuation

    EV/EBITDA
    -0.1x
    P/B
    1.0x
    All RLYB metrics

    RLYB Profitability: Margins, ROIC and FCF

    Rallybio (RLYB) has an operating margin of -5051.0% and a net margin of 6177.0%. It posts a 7139.6% FCF margin.

    Operating margin
    -5051.0%
    Net margin
    6177.0%
    ROE
    34.5%
    FCF margin
    7139.6%
    RLYB financial statements

    The companies most similar to Rallybio (RLYB) include Zura Bio Limited Class A Ordinary Shares, TuHURA Biosciences and Rani Therapeutics Holdings.

    Sector: Healthcare

    Companies most similar to Rallybio

    RLYB Bull Case vs Bear Case

    Bull case

    • RLYB converts 7139.6% of revenue into free cash flow.
    • RLYB has a 6177.0% net profit margin.
    • RLYB beat EPS estimates in 75.0% of its last 8 reported quarters.

    RLYB Earnings: Beat Rate and Next Report

    Rallybio (RLYB) beat the EPS estimate in 6 of the 8 most recent quarters that had an estimate (75.0%).

    Beat rate
    6 of 8 quarters (75.0%)
    Average surprise
    62.1%
    EPS estimate (fiscal period ending Dec 31, 2026)
    -$1.61
    RLYB earnings history

    RLYB Dividend

    Forward yield
    0.0%
    Payout ratio
    0.0%
    Pay months
    Nov

    RLYB ETF Holders

    GNG tracks 2 ETFs that hold RLYB. The largest weights:

    1. Dimensional U.S. Core Equity 2 ETF (DFAC), <0.01% of the fund
    2. Vanguard Extended Market Index Fund ETF Shares (VXF), <0.01% of the fund
    Open the ETF Stock Exposure tool for RLYB

    See insider activity

    Updated Nov 6, 2026. Built from end-of-day prices, company filings and consensus analyst estimates. Methodology

    Frequently Asked Questions About RLYB

    Does RLYB pay dividends?

    Rallybio Corp (RLYB) has a dividend payment track record. See the RLYB dividend history page for its current payment status, TTM yield, and recorded payments.

    What is RLYB's market cap?

    Rallybio Corp (RLYB) has a market capitalization of $88.03M with a current stock price of $15.43.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.